EP3363807
PHARMACEUTICAL COMPOSITION COMPRISING CRYSTALLINE (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL (S)-PROPYLENE GLYCOL SOLVATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.6.2007EP published:
13.11.2019EP application number:
17203302.9
EPO information:
European Patent Register
Max expiry date:
20.6.2027
Title:
PHARMACEUTICAL COMPOSITION COMPRISING CRYSTALLINE (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL (S)-PROPYLENE GLYCOL SOLVATE
Timeline
Today
21.6.2007EP application
13.11.2019EP Publication
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
GOUGOUTAS, Jack Z.Address:
Princeton, NJ New Jersey, US
Name:
NIRSCHL, Alexandra A.Address:
Yardley, PA Pennsylvania, US
Name:
SINGH, JanakAddress:
Pennington, NJ New Jersey, US
Name:
DIMARCO, John D.Address:
Princeton, NJ New Jersey, US
Name:
LOBINGER, HildegardAddress:
Regensburg, DE
Name:
RAMAKRISHNAN, SrividyaAddress:
Miltown, NJ New Jersey, US
Name:
DESHPANDE, Prashant P.Address:
New Brunswick, NJ New Jersey, US
Name:
BIEN, Jeffrey T.Address:
New Brunswick, NJ New Jersey, US
Name:
LAI, ChiajenAddress:
New Brunswick, NJ New Jersey, US
Name:
WANG, ChenchiAddress:
New Brunswick, NJ New Jersey, US
Name:
RIEBEL, PeterAddress:
Ruhstorf A. d. Rott, DE
Name:
GROSSO, John AnthonyAddress:
Princeton Junction, NJ New Jersey, US
Priority
Number:
817118 PDate:
28.6.2006Country:
US
Number:
765481Date:
20.6.2007Country:
US
Classification
Categories:
C07H 7/04, C07H 15/207, A61K 31/70, A61K 31/7034, A61K 45/06, A61P 3/10